Cargando…
Single Positive Core Prostate Cancer in a 12-Core Transrectal Biopsy Scheme: Clinicopathological Implications Compared with Multifocal Counterpart
PURPOSE: The incidence of single positive core prostate cancer at the time of biopsy appears to be increasing in the prostate-specific antigen (PSA) era. To determine the clinical implication of this disease, we analyzed surgical and pathological characteristics in comparison with multiple positive...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Korean Urological Association
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2963778/ https://www.ncbi.nlm.nih.gov/pubmed/21031085 http://dx.doi.org/10.4111/kju.2010.51.10.671 |
_version_ | 1782189309949902848 |
---|---|
author | Ahn, Hong Jae Ko, Young Hwii Jang, Hoon Ah Kang, Sung Gu Kang, Seok Ho Park, Hong Seok Lee, Jeong Gu Kim, Je Jong Cheon, Jun |
author_facet | Ahn, Hong Jae Ko, Young Hwii Jang, Hoon Ah Kang, Sung Gu Kang, Seok Ho Park, Hong Seok Lee, Jeong Gu Kim, Je Jong Cheon, Jun |
author_sort | Ahn, Hong Jae |
collection | PubMed |
description | PURPOSE: The incidence of single positive core prostate cancer at the time of biopsy appears to be increasing in the prostate-specific antigen (PSA) era. To determine the clinical implication of this disease, we analyzed surgical and pathological characteristics in comparison with multiple positive core disease. MATERIALS AND METHODS: Among 108 consecutive patients who underwent robotic radical prostatectomy following a diagnosis of prostate cancer based on a 12-core transrectal biopsy performed by the same method in a single institute, outcomes from 26 patients (Group 1) diagnosed on the basis of a single positive biopsy core and from 82 patients (Group 2) with multiple positive biopsy cores were analyzed. RESULTS: The preoperative PSA value, Gleason score, prostate volume, and D'Amico's risk classification of each group were similar. The proportion of intermediate+highrisk patients was 69.2% in Group 1 and 77.9% in Group 2 (p=0.22). Total operative time and blood loss were similar. Based on prostatectomy specimens, only 3 patients (11.5%) in Group 1 met the criteria for an indolent tumor (7.31% in Group 2). Although similarities were observed during preoperative clinical staging (p=0.13), the final pathologic stage was significantly higher in Group 2 (p=0.001). The positive-margin rate was also higher in Group 2 (11.5% vs. 31.7%, p=0.043). Despite similarity in upstaging after prostatectomy in each group (p=0.86), upgrading occurred more frequently in Group 1 (p=0.014, 42.5% vs. 19.5%). No clinical parameters were valuable in predicting upgrading. CONCLUSIONS: Most single positive core prostate cancer diagnoses in 12-core biopsy were clinically significant with similar risk stratification to multiple positive core prostate cancers. Although the positive-margin rate was lower than in multiple positive core disease, an increase in Gleason score after radical prostatectomy occurred more frequently. |
format | Text |
id | pubmed-2963778 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | The Korean Urological Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-29637782010-10-28 Single Positive Core Prostate Cancer in a 12-Core Transrectal Biopsy Scheme: Clinicopathological Implications Compared with Multifocal Counterpart Ahn, Hong Jae Ko, Young Hwii Jang, Hoon Ah Kang, Sung Gu Kang, Seok Ho Park, Hong Seok Lee, Jeong Gu Kim, Je Jong Cheon, Jun Korean J Urol Original Article PURPOSE: The incidence of single positive core prostate cancer at the time of biopsy appears to be increasing in the prostate-specific antigen (PSA) era. To determine the clinical implication of this disease, we analyzed surgical and pathological characteristics in comparison with multiple positive core disease. MATERIALS AND METHODS: Among 108 consecutive patients who underwent robotic radical prostatectomy following a diagnosis of prostate cancer based on a 12-core transrectal biopsy performed by the same method in a single institute, outcomes from 26 patients (Group 1) diagnosed on the basis of a single positive biopsy core and from 82 patients (Group 2) with multiple positive biopsy cores were analyzed. RESULTS: The preoperative PSA value, Gleason score, prostate volume, and D'Amico's risk classification of each group were similar. The proportion of intermediate+highrisk patients was 69.2% in Group 1 and 77.9% in Group 2 (p=0.22). Total operative time and blood loss were similar. Based on prostatectomy specimens, only 3 patients (11.5%) in Group 1 met the criteria for an indolent tumor (7.31% in Group 2). Although similarities were observed during preoperative clinical staging (p=0.13), the final pathologic stage was significantly higher in Group 2 (p=0.001). The positive-margin rate was also higher in Group 2 (11.5% vs. 31.7%, p=0.043). Despite similarity in upstaging after prostatectomy in each group (p=0.86), upgrading occurred more frequently in Group 1 (p=0.014, 42.5% vs. 19.5%). No clinical parameters were valuable in predicting upgrading. CONCLUSIONS: Most single positive core prostate cancer diagnoses in 12-core biopsy were clinically significant with similar risk stratification to multiple positive core prostate cancers. Although the positive-margin rate was lower than in multiple positive core disease, an increase in Gleason score after radical prostatectomy occurred more frequently. The Korean Urological Association 2010-10 2010-10-21 /pmc/articles/PMC2963778/ /pubmed/21031085 http://dx.doi.org/10.4111/kju.2010.51.10.671 Text en Copyright © The Korean Urological Association, 2010 http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Ahn, Hong Jae Ko, Young Hwii Jang, Hoon Ah Kang, Sung Gu Kang, Seok Ho Park, Hong Seok Lee, Jeong Gu Kim, Je Jong Cheon, Jun Single Positive Core Prostate Cancer in a 12-Core Transrectal Biopsy Scheme: Clinicopathological Implications Compared with Multifocal Counterpart |
title | Single Positive Core Prostate Cancer in a 12-Core Transrectal Biopsy Scheme: Clinicopathological Implications Compared with Multifocal Counterpart |
title_full | Single Positive Core Prostate Cancer in a 12-Core Transrectal Biopsy Scheme: Clinicopathological Implications Compared with Multifocal Counterpart |
title_fullStr | Single Positive Core Prostate Cancer in a 12-Core Transrectal Biopsy Scheme: Clinicopathological Implications Compared with Multifocal Counterpart |
title_full_unstemmed | Single Positive Core Prostate Cancer in a 12-Core Transrectal Biopsy Scheme: Clinicopathological Implications Compared with Multifocal Counterpart |
title_short | Single Positive Core Prostate Cancer in a 12-Core Transrectal Biopsy Scheme: Clinicopathological Implications Compared with Multifocal Counterpart |
title_sort | single positive core prostate cancer in a 12-core transrectal biopsy scheme: clinicopathological implications compared with multifocal counterpart |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2963778/ https://www.ncbi.nlm.nih.gov/pubmed/21031085 http://dx.doi.org/10.4111/kju.2010.51.10.671 |
work_keys_str_mv | AT ahnhongjae singlepositivecoreprostatecancerina12coretransrectalbiopsyschemeclinicopathologicalimplicationscomparedwithmultifocalcounterpart AT koyounghwii singlepositivecoreprostatecancerina12coretransrectalbiopsyschemeclinicopathologicalimplicationscomparedwithmultifocalcounterpart AT janghoonah singlepositivecoreprostatecancerina12coretransrectalbiopsyschemeclinicopathologicalimplicationscomparedwithmultifocalcounterpart AT kangsunggu singlepositivecoreprostatecancerina12coretransrectalbiopsyschemeclinicopathologicalimplicationscomparedwithmultifocalcounterpart AT kangseokho singlepositivecoreprostatecancerina12coretransrectalbiopsyschemeclinicopathologicalimplicationscomparedwithmultifocalcounterpart AT parkhongseok singlepositivecoreprostatecancerina12coretransrectalbiopsyschemeclinicopathologicalimplicationscomparedwithmultifocalcounterpart AT leejeonggu singlepositivecoreprostatecancerina12coretransrectalbiopsyschemeclinicopathologicalimplicationscomparedwithmultifocalcounterpart AT kimjejong singlepositivecoreprostatecancerina12coretransrectalbiopsyschemeclinicopathologicalimplicationscomparedwithmultifocalcounterpart AT cheonjun singlepositivecoreprostatecancerina12coretransrectalbiopsyschemeclinicopathologicalimplicationscomparedwithmultifocalcounterpart |